What are the side effects of gabapentin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Side Effects of Gabapentin

The most common side effects of gabapentin include somnolence, dizziness, and ataxia, with approximately 10% of patients discontinuing treatment due to adverse effects. 1

Common Side Effects

Gabapentin's side effect profile is well-documented in both FDA labeling and clinical guidelines. The most frequently reported adverse effects include:

Central Nervous System Effects

  • Somnolence/sedation (19-21%) 1, 2
  • Dizziness (17-28%) 1, 2
  • Ataxia (13%) 1
  • Fatigue (11%) 1
  • Nystagmus (8%) 1
  • Tremor (7%) 1
  • Thinking abnormal (2-3%) 1

Gastrointestinal Effects

  • Dry mouth (5%) 1
  • Nausea (4%) 1
  • Constipation (4%) 1
  • Diarrhea (6%) 1
  • Vomiting (3%) 1

Other Common Effects

  • Peripheral edema (7-8%) 3, 1
  • Weight gain (2-3%) 2, 1
  • Visual disturbances (amblyopia/blurred vision) (3-4%) 1
  • Diplopia (6%) 1

Serious Side Effects

While generally well-tolerated, gabapentin can cause several serious adverse effects that require monitoring:

  • Suicidal thoughts and behavior: Like other antiepileptic drugs, gabapentin carries an increased risk of suicidal thoughts or actions (approximately 1 in 500 patients) 1

  • Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity: A rare but serious allergic reaction 1

  • Neuropsychiatric effects: Particularly in pediatric patients 3-12 years of age, including emotional lability, hostility, and hyperkinesia 1

  • Withdrawal-precipitated seizures: Abrupt discontinuation can lead to increased seizure frequency 1

  • Cardiovascular effects: Rare cases of atrial fibrillation have been reported, particularly in older adults 4

Side Effect Rates and Discontinuation

  • Approximately 11% of patients discontinue gabapentin due to adverse effects compared to 8.2% with placebo 5

  • In clinical trials for hot flashes, about 10% of patients discontinued gabapentin due to side effects, which is lower than the 40% discontinuation rate seen with clonidine 3

  • Side effects are typically transient and dose-related, with most adverse events occurring during the titration phase 6

Factors Affecting Side Effect Risk

Several factors can increase the risk of experiencing side effects:

  • Dose: Higher doses (>900 mg daily) are associated with increased efficacy but also more side effects 2, 7

  • Age: Elderly patients may be more susceptible to adverse effects, particularly neuropsychological reactions 2

  • Renal impairment: Gabapentin requires dose adjustment in patients with reduced kidney function 2

  • Concomitant medications: Combining gabapentin with other CNS depressants can increase sedation 1

Management of Side Effects

To minimize adverse effects:

  1. Start low, go slow: Begin with lower doses (300 mg once daily) and gradually titrate up 2

  2. Divided dosing: Administer in three divided doses to minimize peak-related side effects 2

  3. Evening dosing: Taking a larger portion of the daily dose at bedtime can help manage sedation 2

  4. Monitor closely: Particularly during dose adjustments and in high-risk populations 1

  5. Avoid abrupt discontinuation: Taper gradually to prevent withdrawal symptoms 1

Comparison to Other Medications

When compared to other medications used for similar indications:

  • Gabapentin has fewer cardiovascular side effects than tricyclic antidepressants 3

  • It has a more favorable side effect profile than opioids for neuropathic pain 3

  • Compared to pregabalin, gabapentin requires slower titration and higher doses but has similar types of side effects 2

Gabapentin's side effect profile should be carefully considered when selecting treatment, particularly in elderly patients or those with comorbidities that might increase risk of adverse effects.

References

Guideline

Pain Management with Gabapentin and Alternative Therapies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Atrial fibrillation induced by gabapentin: a case report.

Journal of medical case reports, 2023

Research

Gabapentin for chronic neuropathic pain in adults.

The Cochrane database of systematic reviews, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.